BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29271116)

  • 1. A Non-Competitive Inhibitor of VCP/p97 and VPS4 Reveals Conserved Allosteric Circuits in Type I and II AAA ATPases.
    Pöhler R; Krahn JH; van den Boom J; Dobrynin G; Kaschani F; Eggenweiler HM; Zenke FT; Kaiser M; Meyer H
    Angew Chem Int Ed Engl; 2018 Feb; 57(6):1576-1580. PubMed ID: 29271116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric activation of VCP, an AAA unfoldase, by small molecule mimicry.
    Jones NH; Liu Q; Urnavicius L; Dahan NE; Vostal LE; Kapoor TM
    Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2316892121. PubMed ID: 38833472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
    Wang Q; Song C; Yang X; Li CC
    J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.
    Segura-Cabrera A; Tripathi R; Zhang X; Gui L; Chou TF; Komurov K
    Sci Rep; 2017 Mar; 7():44912. PubMed ID: 28322292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Vps4 with circular peptides and implications for translocation of two polypeptide chains by AAA+ ATPases.
    Han H; Fulcher JM; Dandey VP; Iwasa JH; Sundquist WI; Kay MS; Shen PS; Hill CP
    Elife; 2019 Jun; 8():. PubMed ID: 31184588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the AAA
    Rao MV; Williams DR; Cocklin S; Loll PJ
    J Biol Chem; 2017 Nov; 292(45):18392-18407. PubMed ID: 28939772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
    Lan B; Chai S; Wang P; Wang K
    Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAA+ ATPase p97/VCP mutants and inhibitor binding disrupt inter-domain coupling and subsequent allosteric activation.
    Caffrey B; Zhu X; Berezuk A; Tuttle K; Chittori S; Subramaniam S
    J Biol Chem; 2021 Oct; 297(4):101187. PubMed ID: 34520757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and mechanism of the ESCRT pathway AAA+ ATPase Vps4.
    Han H; Hill CP
    Biochem Soc Trans; 2019 Feb; 47(1):37-45. PubMed ID: 30647138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-directed AAA+ ATPase p97/VCP unfolds stable proteins crosslinked to DNA for proteolysis by SPRTN.
    Kröning A; van den Boom J; Kracht M; Kueck AF; Meyer H
    J Biol Chem; 2022 Jun; 298(6):101976. PubMed ID: 35469923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric activation of VCP, a AAA unfoldase, by small molecule mimicry.
    Jones NH; Liu Q; Urnavicius L; Dahan NE; Vostal LE; Kapoor TM
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding sites in brain p97/VCP (valosin-containing protein), a multifunctional AAA ATPase.
    Zalk R; Shoshan-Barmatz V
    Biochem J; 2003 Sep; 374(Pt 2):473-80. PubMed ID: 12747802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases.
    Valimehr S; Sethi A; Shukla M; Bhattacharyya S; Kazemi M; Rouiller I
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adapted ATPase domain communication overcomes the cytotoxicity of p97 inhibitors.
    Wei Y; Toth JI; Blanco GA; Bobkov AA; Petroski MD
    J Biol Chem; 2018 Dec; 293(52):20169-20180. PubMed ID: 30381397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer.
    Wang X; Bai E; Zhou H; Sha S; Miao H; Qin Y; Liu Z; Wang J; Zhang H; Lei M; Liu J; Hai O; Zhu Y
    Bioorg Med Chem; 2019 Feb; 27(3):533-544. PubMed ID: 30606672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p97/VCP adaptor UBXD1 drives AAA+ remodeling and ring opening through multi-domain tethered interactions.
    Braxton JR; Altobelli CR; Tucker MR; Tse E; Thwin AC; Arkin MR; Southworth DR
    Nat Struct Mol Biol; 2023 Dec; 30(12):2009-2019. PubMed ID: 37945741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human AAA-ATPase VPS4A isoform and its co-factor VTA1 have a unique function in regulating mammalian cytokinesis abscission.
    Dvilansky I; Altaras Y; Kamenetsky N; Nachmias D; Elia N
    PLoS Biol; 2024 Apr; 22(4):e3002327. PubMed ID: 38687820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural remodeling of AAA+ ATPase p97 by adaptor protein ASPL facilitates posttranslational methylation by METTL21D.
    Petrović S; Roske Y; Rami B; Phan MHQ; Panáková D; Heinemann U
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2208941120. PubMed ID: 36656859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of ubiquitin-independent PP1 complex disassembly by p97.
    van den Boom J; Marini G; Meyer H; Saibil HR
    EMBO J; 2023 Jul; 42(14):e113110. PubMed ID: 37264685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities.
    Wang Q; Song C; Li CC
    Biochem Biophys Res Commun; 2003 Jan; 300(2):253-60. PubMed ID: 12504076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.